10QSB 1 f10qsbthird2007111307final.htm 10QSB THIRD QUARTER 2007 UNITED STATES

Table of Contents


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-QSB

(Mark One)

[X]  QUARTERLY  REPORT  PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

For the quarterly period ended September 30, 2007.


[   ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ________


Commission file no.      333-125678


PROBE MANUFACTURING, INC.

(Exact name of issuer as specified in its charter)


NEVADA

(State or other jurisdiction of

Incorporation or organization)

20-2675800

(I.R.S. Employer

Identification No.)



25242 Arctic Ocean Drive

 Lake Forest, California 92630

(Address of principal executive offices including zip code)


(949) 206-6868

(Issuer’s telephone number, including area code)


Securities registered under Section 12(b) of the Exchange Act:     NONE.


Securities registered under Section 12(g) of the Exchange Act:


COMMON STOCK, PAR VALUE $0.001 PER SHARE.

(Title of class)


Check whether the Issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     X        No ______    


Indicate by check mark whet her the registrant is a shell company (as defined by Rule 12b-2 of the Security Exchange Act)   Yes ______   No     X    .          


As of September 30, 2007, the Issuer had 10,273,321 shares of common stock outstanding.


Transitional Small Business Disclosure Format (check one): Yes _____ No     X    .



1


_______________________________________________________________________________________________


Table of Contents



PROBE MANUFACTURING, INC.

10-QSB


TABLE OF CONTENTS

 

 

PART I.  FINANCIAL INFORMATION


Page


Item 1.

Financial Statements

 

Report of independent registered public accounting firm

F - 1

Balance Sheet as of September 30, 2007 (un-audited) and December 31, 2006

F - 2

Statement of Operations for the three and nine month periods ended September 30, 2007 and 2006 (unaudited)

F - 3

Statements of Cashflows for the nine months ended September 30, 2007 and 2006 (un-audited)

F – 4

Foot Notes to the Financial Statements

F – 5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Plan of Operations

3

Item 3.

Controls and Procedures

12



 

PART II.  OTHER  INFORMATION

 

Item 1.

Legal  Proceedings

12

Item 2.

Unregistered Sales of Equity Securities and Use of  Proceeds

12

Item 3.

Defaults  Upon  Senior  Securities

12

Item 4.

Submission  of  Matters  to  a  Vote  of  Security  Holders

12

Item 5.

Other  Information

12

Item 6.

Exhibits   

13

Item 7.

Reports on Form 8-k

16




2


_______________________________________________________________________________________________


Table of Contents



Item 1.       Financial statements


JASPERS + HALL, PC

CERTIFIED PUBLIC ACCOUNTANTS


9175 E Kenyon Avenue

Denver, CO 80237

303-796-0099





REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors

Probe Manufacturing, Inc.

Lake Forest, CA


We have reviewed the accompanying balance sheet of Probe Manufacturing, Inc. as of September 30, 2007, and the related statements of operations for the three and nine month periods ended September 30, 2007 and cash flows for the nine month periods ended September 30, 2007. These financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the accompanying interim financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  As discussed in Note 1, conditions exist which raise substantial doubt about the Company’s ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.




/s/ Jaspers + Hall, PC

November 9, 2006








F - 3

_______________________________________________________________________________________________


            


Table of Contents



PROBE MANUFACTURING, INC.

Balance Sheet

 

 

Unaudited

 

 

 

September 30, 2007

December 31, 2006

Assets

 

 

Current Assets:

 

 

 

 Cash

 $                    37,766 

 $           42,580 

 

Accounts receivable - trade – net

                     728,364 

            902,767 

 

Inventory

                     893,336 

         1,022,931 

 

Total Current Assets

         1,659,466 

         1,968,278 

Property And Equipment – Net

            248,633 

            317,843 

Total Assets

            $               1,908,099 

 $      2,286,121 

 

 

 

 

 

 

 

 

Liabilities And Stockholders' Deficit

 

 

Current Liabilities:

 

 

 

Accounts payable – trade

 $                  594,276 

 $         629,598 

 

Accrued Expenses

                     224,839 

            273,487 

 

Notes payable

                        - 

              23,496 

 

Current Portion of LT Debt

         1,063,484 

         1,174,383 

 

Total Current Liabilities

         1,882,599 

         2,100,964 

Long-Term Debt:

 

 

 

Other long-term debt

                  1,030,769 

         1,346,595 

 

Capital lease settlement obligations

            368,153 

            758,408 

 

Less Current portion of Long Term Debt

        (1,063,484)

        (1,174,383)

 

Total Long-Term Debt

            335,438 

            930,620 

Total Liabilities

         2,218,037 

         3,031,584 

 

 

 

 

Stockholders' Deficit:

 

 

 

Common Stock to issue

              56,712 

              42,533 

 

Common stock, $.001 par value; 200,000,000 shares authorized; 10,273,321 and 10,162,608 shares issued and outstanding respectively

              10,273 

              10,162 

 

Additional paid-in capital

            102,853 

              60,431 

 

Accumulated deficit

           (479,776)

           (858,589)

 

Total Stockholders' Deficit

           (309,938)

           (745,463)

Total Liabilities And Stockholders' Deficit

 $            1,908,099 

 $        2,286,121 


See Accountants’ review report





F - 4

_______________________________________________________________________________________________


            


Table of Contents



Probe Manufacturing, Inc.

Statement of Operations

for the three and nine month periods ended

September 30, 2007 and 2006 respectively

 

 

 

 

 

 

Unaudited

Unaudited

 

Three-month period ended

Nine-month period ended

 

2007

2006

2007

2006

Sales

$1,566,499

$2,551,236

$5,251,132

$7,313,672

Cost Of Goods Sold

        1,161,335

        1,938,658

        3,886,694

        5,460,204

Gross Profit

           405,164

           612,578

        1,364,438

        1,853,468

 

 

 

 

 

General And Administrative

           329,446

           517,294

        1,121,000

        1,447,245

Research and Development

             31,587

 

             75,378

 

Net Profit / (Loss) From Operations

             44,131

             95,284

           168,060

           406,223

 

 

 

 

 

Other Income / (Expenses)

               1,142

                  423

               1,142

           (37,444)

Gain on Debt Settlement

                      -

 

           324,484

 

Interest Expense

           (42,039)

           (55,382)

         (114,875)

         (208,460)

Net Profit / (Loss) Before Income Taxes

               3,234

             40,325

           378,811

           160,319

Income Tax Expense

                      -

                      -

                      -

                      -

Net Profit / (Loss)

$3,234

$40,325

$378,811

$160,319

 

 

 

 

 

Per Share Information:

 

 

 

 

Basic weighted average number

 

 

 

 

of common shares outstanding

      10,352,198

        7,737,247

      10,312,307

        4,879,189

 

 

 

 

 

Net Profit / (Loss) per common share

$0.0003

$0.0052

$0.0367

$0.0329

 

 

 

 

 

Per Share Information:

 

 

 

 

Diluted, weighted average number

 

 

 

 

of common shares outstanding

      14,983,953

      11,813,497

      14,865,361

        8,940,507

 

 

 

 

 

Diluted, Net Profit / (Loss) per common share

$0.0002

$0.0034

$0.0255

$0.0179


See Accountants’ review report





F - 5

_______________________________________________________________________________________________


            


Table of Contents



PROBE MANUFACTURING, INC.

Statements of Cash Flows

for the Nine months ended September 30,

 

 

 

 

 

 

 

 

Unaudited

Unaudited

 

 

 

2007

2006

Cash Flows from Operating Activities:

 

 

 

Net Income / ( Loss )

 $         378,811

 $         160,318

 

Adjustments to reconcile net loss to net cash

 

 

 

 

used in operating activities:

 

 

 

 

Depreciation and amortization

            194,603

            148,080

 

 

Gain on debt settlement

           (324,484)

 

 

 

Stock issued for Interest

                      -   

              57,395

 

 

Stock for Services

              56,712

            104,656

 

 

Changes in assets and liabilities:

 

 

 

 

(Increase) decrease in accounts receivable

            174,403

           (176,295)

 

 

(Increase) decrease in inventory

            129,595

           (100,437)

 

 

(Increase) decrease in other assets

                      -   

              62,128

 

 

(Decrease) increase in accounts payable

             (35,322)

            140,640

 

 

Other (Decrease) increase in accrued expenses

             (48,648)

             (31,373)

Net Cash provided / (Used) In Operating Activities

            525,670

            365,112

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

Purchase of property and equipment

           (125,392)

           (155,750)

Cash Flows Used In Investing Activities

           (125,392)

           (155,750)

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

Bank Overdraft / (Repayment)

                      -   

           (154,596)

 

Borrowings / (Payments) under line of credit, net

                      -   

             (27,838)

 

Payments on capital lease settlement obligations

             (65,771)

             (72,343)

 

Proceeds / (Payments) on notes payable

           (339,321)

              72,088

Cash Flows Provided / (used)  By Financing Activities

           (405,092)

           (182,689)

 

 

 

 

 

Net (Decrease) Increase in Cash and Cash Equivalents

               (4,814)

              26,673

 

 

 

 

 

Cash and Cash Equivalents at Beginning of Period

              42,580

                      -   

 

 

 

 

 

Cash and Cash Equivalents at End of Period

 $           37,766

 $          26,673

 

 

 

 

 

Supplemental Information:

 

 

 

Interest Paid

 $         114,875

 $        151,065

 

Income Taxes Paid

 $                     -   

 $                    -   

 

Current Lines of credit converted to Long term Notes Payable

$                     -                                

 $        705,000


See Accountants’ review report





F - 6

_______________________________________________________________________________________________


            


Table of Contents



PROBE MANUFACTURING, INC.

Notes to Financial Statements

(Unaudited)


Notes 1- GENERAL


The Company

Probe Manufacturing Industries, Inc. was incorporated on July 7, 1995. On April 21, 2005, the Company was re-domiciled from California to Nevada, and changed its name to Probe Manufacturing, Inc.  Probe Manufacturing, Inc. (the “Company” or “Probe”) is a leading provider of advanced electronics manufacturing services, or EMS, to original equipment manufacturers, or OEMs, primarily in the medical device, aerospace, industrial, instrumentation and alternative fuel, segments. This includes end-to-end manufacturing solutions ranging from engineering to manufacturing of printed circuit card assembly, cable assembly, enclosures, complete system integration and testing, as well as global order fulfillment.


Going Concern

The financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets and liquidation of liabilities in the normal course of business. The Company had a net profit of $378,811, generated $525,670 in net cash from operations and improved their total stockholders deficit by $435,525 for the nine months ended, September 30, 2007.  However, they still had a working capital deficit of 223,133 and a shareholder deficit of $309,938 as of September 30, 2007. Therefore the ability of the Company to operate as a going concern is still dependent upon its ability (1) to obtain sufficient debt and/or equity capital and/or (2) to continue generating positive cash flow from operations.


Management is taking the following steps to address this situation: (a) to continue improving operational efficiencies by: (i) re-negotiating direct material cost with all of our suppliers, (ii) by setting up Managed Inventory Solutions, such as bonded inventory and auto-release programs with our major suppliers, whereby they maintain stock at their facilities and deliver “Just-in-Time”.  This will improve the utilization of our line of credits with suppliers and maintains inventory at its lowest value point; however from time to time inventory levels may increase temporarily, due to scheduling issues and acquisition of new customers and/or products;  (iii) by improving all systems and processes across operations and streamlining production lines; (b) we have refinanced our lines of credit with agreement(s) that have more attractive terms, as well as increased our credit lines with suppliers; (c) To increase revenue; (i) we are acquiring new customers that are a better fit for us, (ii) and we are  growing the business with our existing customers with offering more value added; and finally (iii) we’re focusing on more stable customer base such as medical device, aerospace, and alternative fuel industries that have a better chance of  maintaining their manufacturing in Southern California instead of moving it to low cost and offshore regions;  (e)  to ensure long term sustainability of the Company, we’re allocating more resources to develop propriety technology within the alternative energy industry while continuing to operate our EMS business.

The future success of the Company is likely dependent on its ability to attain additional capital to support growth and ultimately, upon its ability to continue profitable operations.  There can be no assurance that the Company will be successful in obtaining such financing, or that it will continue to generate sufficient positive cash flow from operations.  The successful outcome of these or any future activities cannot be determined at this time and there is no assurance that if achieved, the Company will have sufficient funds to execute its business plans. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.


NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:


The Company follows United States Generally Accepted Accounting Principles. Certain of the principles involve selection among alternatives and choices of methods, which are described in the footnotes to the Company’s reviewed financial statements.  





F - 7

_______________________________________________________________________________________________


            


Table of Contents


Cash and Cash Equivalents

The Company maintains the majority of its cash accounts at a commercial bank. The total cash balance is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $100,000 per commercial bank. For purposes of the statement of cash flows the Company considers all cash and highly liquid investments with initial maturities of one year or less to be cash equivalents.


Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates may be materially different from actual financial results. Significant estimates include the recoverability of long-lived assets, the collection of accounts receivable and valuation of inventory and reserves.


Accounts Receivable

The Company grants credit to its customers located within the United States of America; and does not require collateral. The Company’s ability to collect receivables is affected by economic fluctuations in the geographic areas and industries served by the Company.


Reserves for un-collectable amounts are provided, based on past experience and a specific analysis of the accounts.  Although the Company expects to collect amounts due, actual collections may differ from the estimated amounts. As of September 30, 2007, the Company had a reserve for potentially un-collectable accounts of $35,212.


Five (5) customers accounted for approximately 76% of accounts receivable as of September 30, 2007.  The Company’s trade accounts primarily represent unsecured receivables.  Historically, the Company’s bad debt write-offs related to these trade accounts have been insignificant.


Inventory

Inventories are valued at the lower of weighted average cost or market value.   Our industry experiences changes in technology, changes in market value and availability of the raw materials, as well as changing customer demand.  The Company makes provisions for estimated excess and obsolete inventories based on regular audits and cycle counts of our on-hand inventory levels and forecasted customer demands and at times additional provisions are made.  Any inventory write offs are charged to the reserve account. As of September 30, 2007 the Company had a reserve for potentially obsolete inventory of $409,226.


Property and Equipment

Property and equipment are stated at cost. Assets held under capital leases are recorded at lease inception at the lower of the present value of the minimum lease payments or the fair market value of the related assets.  The Company follows the practice of capitalizing property and equipment purchased over $5,000.  The cost of ordinary maintenance and repairs is charged to operations. Depreciation and amortization are computed on the straight-line method over the following estimated useful lives of the related assets:


Furniture and fixtures

3 to 7 years

Equipment

7 to 10 years

Leasehold improvements

2 years (life of the lease)





F - 8

_______________________________________________________________________________________________


            


Table of Contents


Long –Lived Assets

The Company’s management assesses the recoverability of its long-lived assets by determining whether the depreciation and amortization of long lived assets over their remaining lives can be recovered through projected undiscounted future cash flows. The amount of long lived asset impairment if any, is measured based on fair value and is charged to operations in the period in which long lived assets impairment is determined by management. There can be no assurance however, that market conditions will not change or demand for the Company’s services will continue, which could result in impairment of long-lived assets in the future.


Revenue Recognition

Revenue from product and services are recognized at the time goods are shipped or services are provided to the customer, with an appropriate provision for returns and allowances. Terms are generally FOB Origination with the right of inspection and acceptance. The Company has not experienced a material amount of rejected or damaged product.


Fair Value of Financial Instruments

The carrying amount of accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of these financial instruments.


Other Comprehensive Income

The Company has no material components of other comprehensive income (loss) and accordingly, net loss is equal to comprehensive loss in all periods.


Net Profit / (Loss) per Common Share      

Basic profit / (loss) per share is computed on the basis of the weighted average number of common shares outstanding.  At September 30, 2007 the Company had outstanding common shares of 10,273,321, and 125,623 shares to be issued for officer compensation, for a total of 10,351,684 used in the calculation of basic earnings per share.  Basic Weighted average common shares and equivalents at September 30, 2007 were 10,312,307.  As of September 30, 2007 the Company had outstanding warrants to purchase 4,176,250 additional common shares and options to purchase 455,505 additional common shares, which may dilute future earnings per share. Fully diluted weighted average common shares and equivalents at September 30, 2007 were 14,865,361


Research and Development Cost:

To ensure long term sustainability and growth of the company we have started research and development towards growth markets of the future by investing in alternative energy technologies.  While we continue to operate our Electronics Manufacturing business, we are now directing more resources towards developing technologies in the alternative energy industry.  Our alternative energy research and development is focused on the alternative fuel industry as defined by the Energy Policy Act of 1992 (EPAct) including ethanol, natural gas, propane, hydrogen, bio-diesel, electricity and methanol. These fuels are being used worldwide in a variety of vehicle and power generator applications. We believe three independent market factors; economics, energy security/independence and environmental concerns are driving the growth of alternative energy technologies today and will in the foreseeable future. 


Research and Development Costs incurred in association with the alternative fuels technology development (which include salaries and equipment) are expensed as incurred.  We expensed $75,378 in R&D during the nine months ended September 30 2007. We acquired a 125 kW natural gas distributed power generator and are currently converting it to run on Hydrogen as fuel.  Once the conversion is completed, we’ll start validation testing for performance and emission.  This distributed power generator will have near zero carbon based emission and very low NOx emissions. .  When completed, this hydrogen-fueled internal combustion engine will address two major needs:  power and near-zero emissions.  These engines serve as replacement engines for the industrial user who has been dependent upon a manufacturer of traditional gasoline or diesel-fueled industrial engines.  Our second research and development project involves an Engine Control Unit (ECU) to help convert gasoline cars to run on natural gas.  The Solaris project is in prototype stages, and will be 100% Probe’s proprietary technology.  Once completed this functionally advanced and robust Electronics Controller Unit (ECU) can operate under the hood and will be appropriately priced for different vehicle type and markets. 






F - 9

_______________________________________________________________________________________________


            


Table of Contents


Segment Information      

Except as identified above in the research and development section, we operate primarily in a single operating segment providing printed circuit boards and electronic assemblies.


Stock Based Compensation   

The Company has adopted the use of Statement of Financial Accounting Standards No. 123R , “Share-Based Payment”, (SFAS No. 123R)   This Statement requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost is recognized over the period during which an employee is required to provide service in exchange for the award—the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.   This Statement supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees”, and its related implementation guidance and eliminates the alternative to use Opinion 25’s intrinsic value method of accounting that was provided in Statement 123 as originally issued.  

Income Taxes

The Company accounts for income taxes under SFAS No. 109, which requires the asset and liability approach to accounting for income taxes.  Under this method, deferred tax assets and liabilities are measured based on differences between financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse. The net profit for the nine month period ended, September 30, 2007 of $378,811 is offset by previous losses.  As of September 30, 2007 the Company had a net operating loss carry forward of $(479,778). The Company has not booked any deferred tax asset as a result.


NOTE 3 – INVENTORY


Inventories at September 30, 2007 by major classification were comprised of the following:


Raw Material

                   $ 1,131,319

Work in Process

162,773

Finished Goods

8,470

Total

1,302,562

Less Reserve for excess or obsolete inventory

(409,226)

Total Inventory

$    893,336




NOTE 4 – PROPERTY AND EQUIPMENT


Property and equipment were comprised of the following at September 30, 2007:


Furniture and fixtures

$57,046

Equipment

2,390,927

Leasehold improvements

210,403

Total

2,658,376

Less accumulated depreciation and amortization         

(2,409,743)

     Net Fixed Assets

$248,633






F - 10

_______________________________________________________________________________________________


            


Table of Contents



NOTE 5 – ACCRUED EXPENSES


As of September 30, 2007, the Company had the following accrued expenses:


Sales Tax Payable

 $            2,265

Property Tax accrual

               3,500

Accrued Wages

             43,108

 Accrued Interest

               5,827

 Accrued Professional Fees

             48,500

 Accrued Utilities and other rents

             48,196

 Accrued Vacation

             73,443

 Total Accrued Expenses

 $        224,839




NOTE 7 - CAPITAL LEASE SETTLEMENT OBLIGATIONS  


On July 9, 1997 and December 21, 1997, the Company entered into two lease agreements, with Crocker capital, which subsequently assigned the leases to The CIT Group.  In September 2004 the Company had outstanding balances of $457,604 and $556,293 on the two leases and was unable to make the monthly lease payments. As a result, the Company entered into a forbearance agreement with The CIT Group, with monthly payments of $7,500 and an early payment schedule as follows:


The CIT Group would release the Company and its guarantors if one of the following payments were made, less the total of all monthly payments made to that date:


$375,000 if paid by October 25 , 2004

$425,000 if paid by December 25, 2004

$500,000 if paid by June 25, 2005

$550,000 if paid by December 25, 2005

$600,000 if paid by June 25, 2006

$650,000 if paid by December 25, 2006

$700,000 if paid by June 25, 2007


On June 1, 2007 an amended forbearance agreement was entered into:


1)

In consideration of CIT entering into this Addendum, Probe will pay CIT the sum of $7,500 on or before June 25, 2007, which was paid.

2)

Recital B is amended to state that as of June 25, 2007 Probe’s payment obligation to CIT totals $457,500.

3)

Section 2.3 of the Forbearance Agreement is amended to state that probe will pay CIT the amount of $457,500 in sixty-one (61) monthly installments of $7,500 each, commencing on July 25, 2007 and ending on July 25, 2012. If at any time Probe elects to pay in full the remaining balance, upon 30 day written notice, CIT will provide a payoff figure for the remaining balance using a present value rate of 7.0%.

4)

The Company imputed interest at 7% over the term of the payments, which resulted in a present value of $384,025 at June 30, 2007.

5)

This resulted in a gain of  $324,330.

6)

As of September 30, 2007 the outstanding balance was $368,153

 





F - 11

_______________________________________________________________________________________________


            


Table of Contents



NOTE 8 – NOTES PAYABLE


A) Note Payable – secured by deed of trust, 12% interest, originally due on September 2006 to Ashford Capital Transition Fund I, LP, and was subsequently extended to March 2006. The balance of $456,000 was paid in full on March 10, 2006.              


B) Note Payable - dated March 10, 2006 – special use, line of credit in the amount of $90,000, unsecured, 12% interest paid in cash due May 10, 2007, payable to Ashford Capital, LLC.  This note was converted to a term note payable, with an effective date of June 30, 2006, unsecured, 12% interest rate, with a 36 month amortization, payments of $1,997 and a balloon payment of $33,068 on April 15, 2008. As of September 30, 2007 the outstanding balance was $42.415.  


C)  Note Payable – This Note was an operating line of credit, secured by the assets of the Company,   borrowings under this line of credit were at an interest rate of 20% (12% paid in cash and 8% paid in common stock in the Company) per annum, payable to Ed Lassiter.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, at 12% interest rate, with a 36 month amortization, monthly payments of $ $4,650 and a balloon payment of $77,014 on April 15, 2008.  As of September 30, 2007 the outstanding balance was $98,781.  


D)  Note Payable -- This Note was an operating line of credit, secured by the assets of the Company,   borrowings under this line of credit were at an interest rate of 20% (12% paid in cash and 8% paid in common stock in the Company) per annum, payable to William Duncan.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, at 12% interest rate, with a 36 month amortization, monthly payments of $1,661 and a balloon payment of $27,505 on April 15, 2008. As of September 30, 2007 the outstanding balance was $35,279.


E)  Note Payable – This Note was an operating line of credit, secured by the assets of the Company,   borrowings under this line of credit were at an interest rate of 20% (12% paid in cash and 8% paid in common stock in the Company) per annum, payable to Benner Exemption Trust.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, at 12% interest rate, with a 36 month amortization, payments of $4,650 and a balloon payment of $77,014 on April 15, 2008. As of September 30, 2007 the outstanding balance was $98,781.


F) Note Payable – This note was an operating line of credit, secured by the assets of the Company.   Borrowings under this line of credit were at an interest rate of 20% (12% paid in cash and 8% paid in common stock in the Company) per annum, payable to Ashford Capital, LLC .  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, at 12% interest rate, with a 36 month amortization, monthly payments of $3,321 and a balloon payment of $55,010 on April 15, 2008.  As of September 30, 2007 the outstanding balance was $70,558.


G) Note Payable – This Note was an operating line of credit, secured by the assets of the Company,   Borrowings under this line of credit were at an interest rate of 15% per annum, payable to Hoa Mai.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, at 12% interest rate, with a 36 month amortization, monthly payments of $ $1,661 and a balloon payment of $27,505 on April 15, 2008.  As of September 30, 2007 the outstanding balance was $35,279.  


H) Note Payable – Term note payable, with an effective date of April 23, 2006, secured by assets of the Company, Payable to Hoa Mai at 15% interest rate, with a 12 month amortization, monthly payments of $ 2,166. As of September 30, 2007 the outstanding balance was $14,228.  





F - 12

_______________________________________________________________________________________________


            


Table of Contents



Related Party – Notes payable

I) Note Payable - dated March 10, 2006 – related party, un-secured, 12% interest and ten monthly payments in the amount of $3,650 plus accrued interest. The 1st payment was due on April 10, 2006.  The note is payable to Kambiz Mahdi.  As of September 30, 2007 the balance was $ 0.


J) Note Payable - dated March 10, 2006 – related party, un-secured, 12% interest, and ten monthly payments in the amount of $3,650 plus accrued interest. The 1st payment was due on April 10, 2006.  The note is payable to Reza Zarif.  As of September 30, 2007 the balance was $ 0.


K) Note Payable - dated March 10, 2006  – related party, special use, line of credit in the amount of $45,000, unsecured, 20% interest (10% paid in Cash and 10% paid in Company stock),  due May 10, 2007.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, 12% interest rate, with a 36 month amortization, monthly payments of $1,001 and a balloon payment of $16,588 on April 15, 2008.  This note is payable to Kambiz Mahdi.  As of September 30, 2007 the outstanding balance was $21,277.


L) Note Payable - dated March 10, 2006  – related party, special use, line of credit in the amount of $45,000, unsecured, 20% interest (10% paid in Cash and 10% paid in Company stock),  due May 10, 2007.   This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, 12% interest rate, with a 36 month amortization, monthly payments of $1,001 and a balloon payment of $16,588 on April 15, 2008.  This note is payable to Reza Zarif.  As of September 30, 2007, the outstanding balance was $21,277.  


M) Note Payable – related party, unsecured, 20% interest (10% paid in Cash and 10% paid in Company stock) due on May 10, 2007, Payable to Kambiz Mahdi.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, At 12% interest rate, with a 36 month amortization, monthly payments of $7,871 and a balloon payment of $130,366 on April 15, 2008.   As of September 30, 2007 the outstanding balance was $167,214.

 

N) Note Payable – related party, unsecured, 20% interest (10% paid in Cash and 10% paid in Company stock) due on May 10, 2007, Payable to Reza Zarif.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, At 12% interest rate, with a 36 month amortization, monthly payments of $7,871 and a balloon payment of $130,366 on April 15, 2008. As of September 30, 2007 the outstanding balance was $167,214.


O)  Note Payable – related party.  This note was an operating line of credit, secured by the assets of the Company. Borrowings under this line of credit were at an interest rate of 20% (12% paid in cash and 8% paid in common stock in the Company) per annum, payable to Rufina Paniego.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, 12% interest rate, with a 36 month amortization, monthly payments of $2,491 and a balloon payment of $41,257 on April 15, 2008.  As of September 30, 2007 the outstanding balance was $52,919.


P)  Note Payable – related party.  This note was an operating line of credit, secured by the assets of the Company.   Borrowings under this line of credit were at an interest rate of 20% (12% paid in cash and 8% paid in common stock in the Company) per annum, payable to eFund Capital Partners.  This note was converted to a term note payable, with an effective date of June 30, 2006, un-secured, at 12% interest rate, with a 36 month amortization, monthly payments of $4,982 and a balloon payment of $82,516 on April 15, 2008. As of September 30, 2007 the outstanding balance was $105,838.


Q)  Note Payable – related party.  This is a term note payable, secured by the assets of the Company. Borrowings under this term note were at an interest rate of 15%, with 12 months amortization, monthly payments of $2,256 payable to Rufina Paniego. As of September 30, 2007 the outstanding balance was $12,964.





F - 13

_______________________________________________________________________________________________


            


Table of Contents



Other Long-Term Debt

Other long-term debt consists of, a settlements reached with I-Source, a supplier, with monthly payments of $2,500. As of September 30, 2007 their balance was $16,925. Payments continue through May, 2008.



NOTE 9 – COMMITMENTS AND CONTIGENCIES


Operating Rental Leases

On September 11, 2006 we entered into a sublease agreement for 10,000 sq ft. of manufacturing space which includes office space with Quantum Fuel System Technologies Worldwide, Inc. The initial lease which ends on May 31, 2008 has an option to renew for three years, contingent upon Quantum, renewing their master lease. The new facility is located at 25242 Arctic Ocean Drive, Lake Forest, CA 92630.


Litigation

The Company may be involved from time to time in various claims, lawsuits, and disputes with third parties, action involving allegations or discrimination or breach of contract actions incidental in the normal operations of the business.  


We believe that there are no other claims or litigation pending, the outcome of which could have a material adverse effect on our financial condition or operating results.  However, if litigation should arise and the Company was to receive an unfavorable ruling, there is a possibility that it would have a material adverse impact on our financial condition, results of operations, or liquidity of the period in which the ruling occurs, or future periods.


NOTE 10 – CAPITAL STOCK TRANSACTIONS


On April 21, 2005, the Company’s Board of Directors and shareholders approved the following capital stock transactions:


The Company re-domiciled in the state of Nevada, whereby increasing the number of authorized common shares to 200,000,000 and designating a par value of $.001 per share.


On May 25, 2006, the Company’s Board of Directors and shareholders approved the following capital stock transactions:


An amendment to the Articles of Incorporation of the Company authorizing a new series of Preferred stock, which shall be designated as Series C, and shall consist of 15,000 shares.  


Common Stock transactions:

From June 16, 2004 to April 1, 2005 the Company sold 2,221,250 shares of common stock Private Placement Memorandum at $.80 per Share to 49 individuals generating net proceeds of $1,777,000, of which 715,000 shares were sold in 2005, generating net proceeds of $572,000.


During 2005 the Company issued 31,118 shares of common stock, in lieu of interest payments at $.80 per share for a total of $24,894.


In February 2006 the Company issued 13,438 shares of common stock, in lieu of interest payments at $.80 per share for a total of $10,751.


In May 2006 the Company issued 16,336 shares of common stock, in lieu of interest payments at $.80 per share for a total of $13,094.





F - 14

_______________________________________________________________________________________________


            


Table of Contents


On May 25, 2006, The Company issued 500,000 shares of common stock at .10 cents (Market value of shares on that date), for a total of $50,000,  to compensate its directors for services through a stock grant pursuant to Form S-8 in the following amounts:


Name

Amount of Common Stock issued

Kambiz Mahdi

100,000

Reza Zarif

100,000

Barrett Evans

100,000

Jeffrey Conrad

100,000

Dennis Benner

100,000


In August 2006 the Company issued 30,254 shares of common stock, in lieu of interest payments at $.80 per share for a total of $24,205.


In August 2006 the Company issued 11,678 shares of common stock, in lieu of interest payments at $.80 per share for a total of $9,343.


In August 2006 the Company issued 4,205 shares of common stock for officer compensation at $.80 per share for a total of $3,365.


In August 2006 the Company accrued 47,260 shares of common stock for officer compensation at $.10 per share (fair market value at time of accrual) for a total of $4,726. These shares had been classified as issued in quarterly filings.


In September 2006 the Company accrued 29,083 shares of common stock for officer compensation at $ .65 per share (fair market value at time of accrual) for a total of $18,904.


In December 2006 the Company accrued 34,370 shares of common stock for officer compensation at $.55 per share (fair market value at time of accrual) for a total of $18,904.


In July 2006 the Company converted 12,500 shares from Preferred B to Preferred C, 14,040 shares.


In August 2006 the holders of preferred series C elected to convert  14,040 shares into 1,755,000   shares of common stock.


On August 14, 2006 the holders converted 440 shares of the Preferred Series A for 4,544,188 shares of the Company’s common stock.


In the 1st quarter of 2007, the Company issued 110,713 common shares which were accrued but un-issued as of December 31, 2006. For the nine months ended, September 30, 2007 the Company accrued 125,623 common shares for officer compensation, which were accrued but un-issued.


COMMON STOCK

Our Articles of Incorporation authorize us to issue 200,000,000 shares of common stock, par value $0.001 per share. As of September 30, 2007 and December 31, 2006 there were 10,273,321 and 10,162,608 shares of common stock issued and outstanding, respectively.  We also had 125,623 shares to be issued, for officer compensation which were accrued during the period.  All outstanding shares of common stock are, and the common stock to be issued in this offering will be, fully paid and non-assessable.  Each share of our common stock has identical rights and privileges in every respect. The holders of our common stock are entitled to vote upon all matters submitted to a vote of our shareholders and are entitled to one vote for each share of common stock held. There are no cumulative voting rights.


The holders of our common stock are entitled to share equally in dividends and other distributions that our Board of Directors may declare from time to time out of funds legally available for that purpose, if any, after the satisfaction of any prior rights and preferences of any outstanding preferred stock. If we liquidate, dissolve or wind up, the holders of shares of common stock will be entitled to share ratably in the distribution of all of our assets remaining available for distribution after satisfaction of all our liabilities and our obligations to holders of our outstanding preferred stock.





F - 15

_______________________________________________________________________________________________


            


Table of Contents



PREFERRED STOCK

Our Articles of Incorporation authorize us to issue 10,000,000 shares of preferred stock.  We authorized 440 shares of Series A Convertible Preferred Stock and 20,000 shares of Series B Convertible Preferred Stock.  On May 25th, 2006 the Articles of Incorporation were amended authorizing 15,000 shares Series C Convertible Preferred Stock.


Preferred Series A

As of June 30, 2006, there were 440 shares of Convertible A Preferred Stock outstanding, with a stated value of $1,000.  Each share is convertible into 0.1% percent of the shares of our common stock outstanding at the date of conversion, which shall convert upon election of the holder.  The holders of  series A Preferred stock have the right to vote with the holders of common stock on any matter to which the common stock holders are entitled to vote and they are entitled to vote number of shares of common stock into which the series A Preferred Stock is convertible. If we are liquidated, distribute our assets, dissolve or wind-up, the holders of Convertible A Preferred Stock shall receive the greater of (i) $2,500 per share of Convertible A Preferred Stock they hold at the time of such liquidation, or (ii) their pro rata share of the total value of our assets and funds to be distributed, assuming the Convertible A preferred stock is converted to common stock.  On August 14, 2006 the holders converted 440 shares of the Preferred Series A for 4,544,188 shares of the Company’s common stock.


Preferred Series B

As of March 31, 2006 there were 12,500 shares of Series B Convertible stock outstanding, with a stated value of $100. Each share of Series B Stock shall be converted into a number of shares of common stock that is equal to each share being divided by the average of the 3 lowest intraday bids in the twenty (20) days prior to conversion multiplied by 100              (1 divided by x, multiplied by 100), or 125 shares per Series B, whichever is greater.  The minimum conversion price which Series B shareholders shall convert their Series B shares to common stock shall be $0.10.  


Exchange of Preferred Series B to Preferred Series C

On May 25, 2007 the Board of Directors approved the exchange of Series B Convertible Preferred Stock for Series C No-Par, Convertible Preferred Stock for its Series B stockholders.  After the exchange took place Series B Convertible Preferred Stock was cancelled.  The Series C Convertible Preferred Stock carries the same rights as Series B Convertible Preferred Stock except that Series C Convertible Preferred Stock can be redeemed by the Company.  At any time, the Company may, in its sole discretion, redeem some or all of the outstanding shares of Series C Stock at a “Redemption Price” equal to the greater of $120.00 per share for the first year from the date of this certificate and after which the redemption price shall increase by twelve percent (12%) per year until all outstanding shares of Series C have been redeemed.  To redeem Series C Stock, the Company, at least five (5) days prior to the date on which it desires to redeem such stock (the “Redemption Date”), shall send the applicable holder of Series C Stock a notice of the redemption provided, however, that failure to give such notice or any defect therein or in the mailing thereof shall not affect the validity of the proceedings for the redemption of any shares of Series C Stock.  Such notice shall state:  (i) the redemption date; (ii) the redemption price; and (iii) the number of shares of Series C Stock to be redeemed.  Furthermore, the holders of Series C Convertible Preferred Stock shall receive one A Warrant and one B Warrant for every Ten (10) shares of common stock received from converting a share of Series C Convertible Preferred stock of the Company.  This series A and B Warrants are pursuant to the terms and conditions of the Company’s Series A and B warrant agreement as amended.


Preferred Series C

As of June 30, 2006 there were 14,040 shares of Convertible C Preferred Stock outstanding.   Originally as filed on May 25, 2006 each share of Series C Stock shall be converted into a number of shares of Common Stock that is equal to each share being divided by the average of the 3 lowest intraday bids in the twenty (20) days prior to conversion or $0.10, which ever is greater, multiplied by 100 (1 divided by x, multiplied by 100), or 125 shares per Series C, whichever is greater. However, on August 07, 2006 the terms of Series C were amended as follows: Each share of Series C stock shall be converted into a number of shares of Common Stock that is equal to each share being divided $0.80 multiplied by 100      (1 divided by $0.80, multiplied by 100).


On August 14, 2006, the holders of Preferred Series C elected to convert their shares into common stock.  As a result  14, 040 shares of Preferred Series C were converted into 1,755,000 shares of common stock.





F - 16

_______________________________________________________________________________________________


            


Table of Contents


Our Board of Directors has the authority to issue additional shares of preferred stock in one or more series, and fix for each series, the designation of and number of shares to be included in each such series. Our Board of Directors is also authorized to set the powers, privileges, preferences, and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications, limitations or restrictions of the shares of each such series.


Unless our Board of Directors provides otherwise, the shares of all series of preferred stock will rank on parity with respect to the payment of dividends and to the distribution of assets upon liquidation. Any issuance by us of shares of our preferred stock may have the effect of delaying, deferring or preventing a change of our control or an unsolicited acquisition proposal. The issuance of preferred stock also could decrease the amount of earnings and assets available for distribution to the holders of common stock or could adversely affect the rights and powers, including voting rights, of the holders of common stock.


Warrants

Series A - Common Stock Warrants:

We currently have 407,625 Series A Warrants issued and outstanding.  Each warrant gives the holder the right to purchase 5 shares of common stock (2,038,125 total shares) at $1.00 per share.  The Series A Warrants expire on November 15, 2007.


Series B - Common Stock Warrants

We currently have 407,625 Series B Warrants issued and outstanding.  Each warrant gives the holder the right to purchase 5 shares of common stock (2,038,125 total shares) at $1.50 per share.  The Series B Warrants will expire on May 15, 2008.


Series C – Common Stock Warrants

We currently have 200,000 Series C Warrants issued and outstanding.  Each warrant gives the holder the right to purchase 1 shares of common stock (200,000 total shares) at $.80 per share.  The Series C Warrants expire on November 5, 2010.



Warrants Activity for the Period and Summary of Outstanding Warrants

From June 16, 2004 to April 1, 2005 the Company sold 222,125 common stock units pursuant to a private placement memorandum at $8.00 per unit to 49 individuals generating net proceeds of $1,777,000.  On August 14, 2006, 14,040 shares of preferred series C were converted into 1,755,000 shares of the Company’s, common stock..


Each Unit consists of ten (10) shares of common stock.  In addition, each unit entitles the holder to purchase a total of 10 shares of Probe Common Stock through the exercise of Warrants as follows: series A Warrants, for 5 shares at a price of $1.00 per share which would expire on November 16, 2005, which has been subsequently extended to November 15, 2007 and series B Warrants, for 5 shares at a price of $1.50 per share which would expire on May 16, 2005, which was subsequently extended to May 15, 2008.  As of June 30, 2007 no warrants were exercised.  


On August 14, 2006, the holders of Preferred Series C elected to convert their shares into common stock.  As a result 14, 040 shares of Preferred Series C were converted into 1,755,000 shares of common stock.  Furthermore, the holders of Series C Convertible Preferred Stock shall receive one A Warrant and one B warrant for every Ten (10) shares of common stock received from converting a share of Series C convertible Preferred stock of the Company.  


On December 31, 2004, the company issued 100,000 shares of its common stock for services.  Each share of stock issued included two warrants, for a total of 200,000 common share equivalents, which were replaced with series C warrants created, approved and issued on November 5, 2007 by the board of directors.


 





F - 17

_______________________________________________________________________________________________


            


Table of Contents


A summary of warrant activity for the periods is as follows:



 

 

 Warrants - Common Share Equivalents

Adjusted Weighted Average Exercise price

 

 Adjusted Warrants exercisable - Common Share Equivalents

Weighted Average Exercise price

Outstanding December 31, 2003

                -   

 

 

               -   

 

 

Granted

     1,706,250

$1.20

 

    1,706,250

$1.20

 

Exercised

                -   

 

 

               -   

 

Outstanding December 31, 2004

     1,706,250

$1.20

 

    1,706,250

$1.20

 

Granted

       715,000

$1.25

 

       143,000

$1.25

 

Exercised

                -   

 

 

               -   

 

Outstanding December 31, 2005

     2,421,250

$1.21

 

    1,849,250

$1.21

 

Granted

     1,755,000

$1.25

 

       351,000

$1.25

 

Exercised

                -   

 

 

               -   

 

Outstanding December 31, 2006

     4,176,250

$1.23

 

    2,200,250

$1.23

 

Granted

                -   

 

 

               -   

 

 

Exercised

                -   

 

 

               -   

 

Outstanding September 30,2007

     4,176,250

$1.23

 

    2,200,250

$1.23

 

Note: The weighted average exercise price has been adjusted retroactively due to price decreases in the warrant strike prices.


 

Warrants Outstanding

 

 Warrants Exercisable

Range of Warrant Exercise Price

 Warrants - Common Share Equivalents

Weighted Average Exercise price

Weighted Average Remaining Contractual life

 

 Warrants - Common Share Equivalents

Weighted Average Exercise price

$1.00

     1,988,125

$1.00

0.12

 

    1,988,125

$1.00

$1.50

     1,988,125

$1.50

0.63

 

    1,988,125

$1.50

$0.80

       200,000

$0.80

2.25

 

       200,000

$0.80

Total

     4,176,250

 

 

 

    4,176,250

 

 





F - 18

_______________________________________________________________________________________________


            


Table of Contents


STOCK OPTIONS

On February 8, 2007, pursuant to the Company’s 2006 Incentive Option Plan which was adopted by the Company’s Board of Directors granted Company employees an incentive stock option to purchase up to 205,505 shares of common stock in the Company.  These options were granted at $.52 cents, the fair market value of the Company at the time of the grant. These options expire on February 8, 2017.


On February 8, 2007, the Company granted stock options to its key employees, to purchase up to 250,000 shares of the Company’s common stock, which was approved by the company’s Board of Directors.  These options were granted at $.52 cents, the fair market value of the Company at the time of the grant.  These options expire on February 8, 2017.



NOTE 11 – RELATED PARTY TRANSACTIONS


Jeffrey Conrad provides legal services for the Company and receives a monthly retainer of $2,500 and is one of the Company directors.  Jeffrey Conrad is also a venture partner of eFund Capital Partners, LLC. Jeffrey Conrad does not have an equity stake in eFund Capital Partners, LLC.  eFund Capital Partners, LLC received their shares pursuant to an investment agreement with us in April of 2004. Total payments for the nine months ended September 30, 2007 were $9,500.


On May 25, 2006 the holders of Series B Convertible Preferred Stock exchanged their stock for Series C Convertible Preferred Stock.  Pursuant to the exchange Reza Zarif, our CEO, received 4,500 shares of Series C; Kambiz Mahdi received 4,500 shares of series C; and eFund Capital Partners, LLC received 5,040 shares of series C.  As originally filed on May 25, 2006 each share of Series C Stock shall be converted into a number of shares of Common Stock that is equal to each share being divided by the average of the 3 lowest intraday bids in the twenty (20) days prior to conversion or $0.10, which ever is greater, multiplied by 100 (1 divided by x, multiplied by 100), or 125 shares per Series C, whichever is greater.  However, on August 07, 2006 the terms of Series C were amended as follows: Each share of Series C Stock shall be converted into a number of shares of Common Stock that is equal to each share being divided $0.80 multiplied by 100 (1 divided by $0.80, multiplied by 100).







F - 19

_______________________________________________________________________________________________


            


Table of Contents


Item 2.   Management’s Discussion and Analysis of Financial Condition and Plan of Operations


We intend that our forward-looking statements be subject to the safe harbors created by the Exchange Act. The forward-looking statements are generally accompanied by words such as “intend,” “anticipate,” “believe,” “estimate,” “expect” and other similar words and statements and variations or negatives of these words. Our forward-looking statements are based on current expectations, forecasts and assumptions and are subject to risks, uncertainties and changes in condition, significance, value and effect, including those discussed under the heading “Risk Factors” in this report filed with the Securities and Exchange Commission. Such risks, uncertainties and changes in condition, significance, value and effect could cause our actual results to differ materially from our anticipated outcomes. Although we believe that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate. Therefore, we can give no assurance that the results implied by these forward-looking statements will be realized. The inclusion of forward-looking information should not be regarded as a representation by our company or any other person that the future events, plans or expectations contemplated by Probe Manufacturing, Inc. will be achieved. We disclaim any intention or obligation to update or revise any forward-looking statements contained in the documents incorporated by reference herein, whether as a result of new information, future events or otherwise.


Overview

Probe Manufacturing, Inc. was founded in 1995, and is one of Southern California's highest quality  Electronics Manufacturing Services (EMS) companies. We provide a range of quality manufacturing and integrated supply chain services at affordable prices to companies who design and market electronic products, Original Equipment Manufacturers (OEM). Currently, our revenue is generated from sales of our services primarily to customers in the medical devise, aerospace, alternative fuel and industrial products manufacturers. The Company provides OEMs with lowest cost of ownership, flexibility, and quality that improves their competitive advantage. Probe's EMS offerings include new product introduction, collaborative design, materials management, product manufacturing, product warranty repair, and end-of-life support. Because our core business is a service company, we’re impacted by our customer’s ability to appropriately predict market demand for their products. While we work with our customers to understand their demand needs, we are removed from the actual end-market served by our customers. Consequently to determine future trends and estimates of activity can be very difficult. To provide for long term sustainability, the Company is in the process of leveraging its manufacturing and commercializing competencies combined with product knowledge to develop its own propriety products for alternative energy technologies to enable vehicles and generators to operate on clean alternative fuels. Probe Manufacturing's headquarters are located in Lake Forest, California.  


Plan of Operations:


Company had a net profit of $378,811, generated $525,670 in net cash from operations and improved their total stockholders deficit by $435,525 for the nine months ended, September 30, 2007.  However, they still had a working capital deficit of 223,133 and a shareholder deficit of $309,938 as of September 30, 2007. Therefore the ability of the Company to operate as a going concern is still dependent upon its ability (1) to obtain sufficient debt and/or equity capital and/or (2) to continue generating positive cash flow from operations.


Management is taking the following steps to address this situation: (a) to continue improving operational efficiencies by: (i) re-negotiating direct material cost with all of our suppliers, (ii) by setting up Managed inventory Solutions, such as bonded inventory levels and auto-release programs with our major suppliers, whereby they maintain stock at their facilities and deliver “Just-in-Time”.  This will improve the utilization of our line of credits with suppliers and maintains inventory at its lowest value point; however from time to time inventory levels may increase temporarily, due to scheduling issues and acquisition of new customers and/or products;  (iii) by improving all systems and processes across operations and streamlining production lines; (b) we have refinanced our lines of credit with agreement(s) that have more attractive terms, as well as increased our credit lines with suppliers; (c) To increase revenue; (i) we are acquiring new customers that are a better fit for us, (ii) and we are  growing the business with our existing customers with offering more value added; and finally (iii) we’re focusing on more stable customer base such as medical device, aerospace, and alternative fuel industries that have a better chance of  maintaining their manufacturing in Southern California instead of moving it to low cost and offshore regions;  (e)  to ensure long term sustainability of the Company, we’re allocating more resources to develop propriety technology within the alternative energy industry while continuing to operate our EMS business.





 3

______________________________________________________________________________________________


            


Table of Contents


The future success of the Company is likely dependent on its ability to attain additional capital to support growth and ultimately, upon its ability to continue profitable operations.  There can be no assurance that the Company will be successful in obtaining such financing, or that it will continue to generate sufficient positive cash flow from operations.  The successful outcome of these or any future activities cannot be determined at this time and there is no assurance that if achieved, the Company will have sufficient funds to execute its business plans. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.


Selected financial data:

The following selected historical financial information of Probe Manufacturing, Inc. has been derived from the historical financial statements and should be read in conjunction with financial statement and notes included herein and with previous filings.


Statement of Operations

Probe Manufacturing, Inc.

Statement of Operations

for the three and nine month periods ended

September 30, 2007, 2006 and 2005 respectively

 

Unaudited

Unaudited

 

Three-month period ended

nine-month period ended

 

2007

2006

2005

2007

2006

2005

Sales

$1,566,499

$2,551,236

 $1,494,250 

$5,251,132

$7,313,672

 $4,400,649

Cost Of Goods Sold

   1,161,335

   1,938,658

    1,177,232

    3,886,694

    5,460,204

    3,551,466

Gross Profit

      405,164

      612,578

       317,018

    1,364,438

    1,853,468

       849,183

 

 

 

 

 

 

 

General And Administrative

      329,446

      517,294

       495,592

    1,121,000

    1,447,245

    1,352,516

Research and Development

        31,587

 

 

         75,378

 

 

Net Profit / (Loss) From Operations

        44,131

        95,284

      (178,574)

       168,060

       406,223

     (503,333)

 

 

 

 

 

 

 

Other Income / (Expenses)

          1,142

             423

         17,337

           1,142

       (37,444)

         95,584

Gain on Debt Settlement

                  -

 

 

       324,330

 

 

Interest Expense

       (42,039)

       (55,382)

        (56,607)

     (114,875)

     (208,460)

     (131,779)

Net Profit / (Loss) Before Income Taxes

          3,234

        40,325

      (217,844)

       378,657

       160,319

     (539,528)

Income Tax Expense

                  -

                  -

                   -

                   -

                  -

                  -

Net Profit / (Loss)

$3,234

$40,325

($217,844)

$378,657

$160,319

($539,528)

 

 

 

 

 

 

 

Per Share Information:

 

 

 

 

 

 

Basic weighted average number

 

 

 

 

 

 

of common shares outstanding

 10,352,198

   7,737,247

    3,337,778

  10,312,307

    4,879,189

    3,193,981

 

 

 

 

 

 

 

Net Profit / (Loss) per common share

$0.0003

$0.0052

($0.0653)

$0.0367

$0.0329

($0.1689)

 

 

 

 

 

 

 





 4

______________________________________________________________________________________________


            


Table of Contents





Per Share Information:

 

 

 

 

 

 

Diluted, weighted average number

 

 

 

 

 

 

of common shares outstanding

 14,983,953

 11,813,497

 N/A

  14,865,361

    8,940,507

 N/A

 

 

 

 

 

 

 

Diluted, Net Profit / (Loss) per common share

$0.0002

$0.0034

N/A

$0.0255

$0.0179

N/A


Condensed Balance sheet data:


PROBE MANUFACTURING, INC.

Condensed Balance Sheet

As of  September 30, 2007

 

 

 

 

 

2007

2006

2005

Working Capital

($223,134)

($12,216)

($576,610)

Total Assets

1,908,099

2,650,246

2,375,801

Long term Debt

335,438

1,079,650

961,913

Stockholders Equity

($309,938)

($730,452)

($965,402)



Summary of Results:

For the quarter ended September 30, 2007 we generated a net profit of $3,234 compared to net profit of $40,325 for the same period in 2006 and net losses of ($217,844) for the same period in 2005.  For the nine month period ended September 30, 2007 we generated a net profit of $378,657 compared to net profit of $160,319 and net losses of $(539,528) for the same period in 2006 and 2005 respectively.

For the quarter ended September 30, 2007 our revenue decreased by 38% to $1,566,499 compared to $2,551,236 in the same period in 2006 and it increased by 5% from 1,494,250 in the same period in 2005.  For the nine month period ended June 30, 2007 our revenue deceased by 28% to 5,251,132 compared to $7,313,672 in the same period in 2006 and it increased by 20% from 4,400,649 in the same period in 2005.  

For the quarter ended, September 30, 2007 our cost of goods sold, was 74% compared to 76% and 79%  in the same period in 2006 and 2005 respectively.  

For the quarter ended, September 30, 2007 our gross margins were 26% compared to 24% and 21% in the same period in 2006 and 2005 respectively.  

For the quarter ended, September 30, 2007 our SG&A cost was 21% compared to 20% and 33% in the same period in 2006 and 2005 respectively.  

As of September 30, 2007 we still had a working capital deficit of $(223,134) compared to working capital deficit of $(12,216) and working capital deficit of $(576,610) for the same period in 2006 and 2005 respectively.  From September 30, 2005 to September 30, 2007 our stockholders equity improved by $655,464.

Our improvements in performance for the quarter ended, September 30, 2007 compared to the same period in 2005 were primarily due to increase in revenues and continuation of process improvement efforts initiated in the 4th quarter of 2005.    However, the reduction in revenue compared to the same period in 2006 was due primarily to changing our customer base.  As we move more of our customer base to more stable and better fit customers in Medical device, Aerospace and alternative energy manufacturing industries, we disengaged with one of our major customers that accounted for 25% of our sales for the first 9 months of 2006.  During the quarter ended September 30, 2007, another major customer who accounted for 32% of our revenue in the same period in 2006 reduced its orders by 85%.   Despite total disengagement with one major customer, and 85% reduction of orders from another major customer, we were able to further diversify our customer base and maintain profitability.  In addition to diversification, we are focusing our sales on more stable customer base such as medical device manufacturers and aerospace industries that have a better chance of maintaining their manufacturing in Southern California instead of moving it to low cost and offshore regions.

 





 5

______________________________________________________________________________________________


            


Table of Contents


Key performance indicators:


Key Performance Indicators

 Three months ended September 30,

 Nine months ended September

 

2007

2006

2005

2007

2006

2005

Inventory Turns

3.46

3.43

2.54

3.65

3.62

3.15

Days Sales in Backlog

173

93

120

155

97

122

Days Receivables Outstanding

46

31

38

42

29

33

Days Payables Outstanding

78

62

73

63

56

81



Inventory turns: are calculated as the ratio of cost of material compared to the average inventory for the quarter. Despite major changes in our customer base, our inventory turns remained stable at 3.46 for the quarter ended September 30, 2007 compared to 3.43 and 2.54 in the same period in 2006 and 2005 respectively.  


Days Sales in Backlog is calculated based on our back log divided by average daily sales during the quarter.  For the quarter ended, September 30, 2007, Days Sales in Backlog was 173 days compared to 93 days and 120 days in the same period in 2006 and 2005 respectively.  


Days Receivables Outstanding, is calculated as the ratio of average accounts receivable for the quarter compared to average daily sales for the same period. For the quarter ended, September 30, 2007, Days Receivables Outstanding was 46 days compared to 31 days and 38 days in the same period in 2006 and 2005 respectively.  


Days Payable Outstanding, is calculated as the ratio of average accounts payable during the quarter  compared to daily cost of sales for the same period. For the quarter ended, September 30, 2007, Days Payable Outstanding was 78 days compared to 62 days and 73 days in the same period in 2006 and 2005 respectively.  


Critical Accounting Policies

The Company follows United States generally accepted accounting principles. Certain of the principles involve selection among alternatives and choices of methods, which are described in the footnotes to the Company’s reviewed financial statements.  


Cash and Cash Equivalents

The Company maintains the majority of its cash accounts at a commercial bank. The total cash balance is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $100,000 per commercial bank. For purposes of the statement of cash flows, the Company considers all cash and highly liquid investments with initial maturities of one year or less to be cash equivalents.


Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates may be materially different from actual financial results. Significant estimates include the recoverability of long-lived assets, the collection of accounts receivable and valuation of inventory and reserves.





 6

______________________________________________________________________________________________


            


Table of Contents


Accounts Receivable

The Company grants credit to its customer’s within the United States of America and does not require collateral. The Company’s ability to collect receivables is affected by economic fluctuations in the geographic areas and industries served by the Company.


Reserves for un-collectable amounts are provided, based on past experience and a specific analysis of the accounts.  Although the Company expects to collect amounts due, actual collections may differ from the estimated amounts. As of September 30, 2007, the Company had a reserve for potentially un-collectable accounts of $35,212.


Five (5) customers accounted for approximately 76% of accounts receivable at September 30, 2007.  The Company’s trade accounts primarily represent unsecured receivables.  Historically, the Company’s bad debt write-offs related to these trade accounts have been insignificant.


Inventory

Inventories are valued at the lower of weighted average cost or market value.   Our industry experiences changes in technology, changes in market value and availability of the raw materials, as well as changing customer demand.  The Company makes provisions for estimated excess and obsolete inventories based on regular audits and cycle counts of our on-hand inventory levels and forecasted customer demands and at times additional provisions are made.  Any inventory write offs are charged to the reserve account. As of September 30, 2007 the Company had a reserve for potentially obsolete inventory of $409,226.


Property and Equipment

Property and equipment are stated at cost. Assets held under capital leases are recorded at lease inception at the lower of the present value of the minimum lease payments or the fair market value of the related assets.  The Company follows the practice of capitalizing property and equipment purchased over $5,000.  The cost of ordinary maintenance and repairs is charged to operations. Depreciation and amortization are computed on the straight-line method over the following estimated useful lives of the related assets are as follows:


Furniture and fixtures

3 to 7 years

Equipment

7 to 10 years

Leasehold improvements

2 years (life of the lease)


Long –Lived Assets

The Company’s management assesses the recoverability of its long-lived assets by determining whether the depreciation and amortization of long lived assets over their remaining lives can be recovered through projected undiscounted future cash flows. The amount of long lived asset impairment if any, is measured based on fair value and is charged to operations in the period in which long lived assets impairment is determined by management. There can be no assurance however, that market conditions will not change or demand for the Company’s services will continue, which could result in impairment of long-lived assets in the future.


Revenue Recognition

Revenue from product and services are recognized at the time goods are shipped or services are provided to the customer, with an appropriate provision for returns and allowances. Terms are generally FOB Origination with the right of inspection and acceptance. The Company has not experienced a material amount of rejected or damaged product.


Fair Value of Financial Instruments

The carrying amount of accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of these financial instruments.


Other Comprehensive Income

The Company has no material components of other comprehensive income (loss) and accordingly, net loss is equal to comprehensive loss in all periods.





 7

______________________________________________________________________________________________


            


Table of Contents


Net Profit / (Loss) per Common Share      

Basic profit / (loss) per share is computed on the basis of the weighted average number of common shares outstanding.  At September 30, 2007 the Company had outstanding common shares of 10,273,321, and 125,623 shares to be issued for officer compensation, for a total of 10,351,684 used in the calculation of basic earnings per share.  Basic Weighted average common shares and equivalents at September 30, 2007 were 10,312,307.  As of September 30, 2007 the Company had outstanding warrants to purchase 4,176,250 additional common shares and options to purchase 455,505 additional common shares, which may dilute future earnings per share. Fully diluted weighted average common shares and equivalents at September 30, 2007 were 14,865,361


Research and Development Cost:

To ensure long term sustainability and growth of the company we have started research and development towards growth markets of the future by investing in alternative energy technologies.  While we continue to operate our Electronics Manufacturing business, we are now directing more resources towards developing technologies in the alternative energy industry.  Our alternative energy research and development is focused on the alternative fuel industry as defined by the Energy Policy Act of 1992 (EPAct) including ethanol, natural gas, propane, hydrogen, bio-diesel, electricity and methanol. These fuels are being used worldwide in a variety of vehicle and power generator applications. We believe three independent market factors; economics, energy security/independence and environmental concerns are driving the growth of alternative energy technologies today and will in the foreseeable future. 


Research and Development Costs incurred in association with the alternative fuels technology development (which include salaries and equipment) are expensed as incurred.  We expensed $75,378 in R&D during the nine months ended September 30 2007. We acquired a 125 kW natural gas distributed power generator and are currently converting it to run on Hydrogen as fuel.  Once the conversion is completed, we’ll start testing it for performance and emission.  This distributed power generator will have near zero carbon based emission and very low NOx emissions. .  When completed, this hydrogen-fueled internal combustion engine will address two major needs:  power and near-zero emissions.  These engines serve as replacement engines for the industrial user who has been dependent upon a manufacturer of traditional gasoline or diesel-fueled industrial engines.  Our second research and development project involves an Engine Control Unit (ECU) to help convert gasoline cars to run on natural gas.  The Solaris project is in prototype stages, and will be 100% Probe’s proprietary technology.  Once completed this functionally advanced and robust Electronics Controller Units (ECU) that can operate under the hood and will be appropriately priced for different vehicle type and markets. 


Segment Information      

Except as identified above in the research and development section, we operate primarily in a single operating segment providing printed circuit boards and electronic assemblies.


Stock Based Compensation

The Company has adopted the use of Statement of Financial Accounting Standards No. 123R , “Share-Based Payment”, (SFAS No. 123R)   This Statement requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost is recognized over the period during which an employee is required to provide service in exchange for the award—the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.   This Statement supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees”, and its related implementation guidance and eliminates the alternative to use Opinion 25’s intrinsic value method of accounting that was provided in Statement 123 as originally issued.  


Income Taxes

The Company accounts for income taxes under SFAS No. 109, which requires the asset and liability approach to accounting for income taxes.  Under this method, deferred tax assets and liabilities are measured based on differences between financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse. The net profit for the nine month period ended, September 30, 2007 of $375,577 is offset by previous losses.  As of September 30, 2007 the Company had a net operating loss carry forward of $(483,012). The Company has not booked any deferred tax asset as a result.





 8

______________________________________________________________________________________________


            


Table of Contents


Result of operations:

The following table summarizes certain items in the statements of operations as a percentage of net sales. The financial information and the discussion below should be read in conjunction with the accompanying financial statements and notes thereto.


Probe Manufacturing, Inc.

Statement of Operations - Percentage Based

for the three and nine month periods ended

September 30, 2007, 2006 and 2005 respectively

 

 

 

 

 

Unaudited

 

nine-month period ended

 

2007

2006

2005

Sales

100%

100%

100%

Cost Of Goods Sold

74%

75%

81%

Gross Profit

26%

25%

19%

 

 

 

 

General And Administrative

21%

20%

31%

Research and Development

1%

0%

0%

Net Profit / (Loss) From Operations

3%

6%

-11%

 

 

 

 

Other Income / (Expenses)

0%

-1%

2%

Gain on Debt Settlement

6%

0%

0%

Interest Expense

-2%

-3%

-3%

Net Profit / (Loss) Before Income Taxes

7%

2%

-12%

Income Tax Expense

0%

0%

0%

Net Profit / (Loss)

7%

2%

-12%



Net Sales 

 For the quarter ended September 30, 2007 our sales decreased by 38% to 1,566,499 compared to the same period in 2006.  For the nine month ended September 30, 2007 our sales decreased by 28% to $5,251,132 compared to $7,313,672 for the same period in 2006.  This decrease in sales was primarily due to changing customer base.  We disengaged with one of our major customers that accounted for 26% of our sales for the first 6 months of 2006.  Lower sales in 2007 compared to 2006, is primarily due to changing customer base.  Over the last twelve month, we have been moving  our customer base to more stable and better fit partnerships in Medical device, Aerospace and alternative energy manufacturing industries, we disengaged with one of our major customers that accounted for 25% of our sales for the first 9 months of 2006.  During the quarter ended September 30, 2007, another major customer who accounted for 32% of our revenue in the same period in 2006 reduced its orders by 85%.   Despite total disengagement with one major customer, and 85% reduction of orders from another major customer, we were able to further diversify our customer base (see Major Customers below), and maintain profitability.  In addition to diversification, we are focusing our sales on more stable customer base such as medical device manufacturing and aerospace industries that have a better chance of maintaining their manufacturing in Southern California instead of moving it to low cost and offshore regions.





 9

______________________________________________________________________________________________


            


Table of Contents


Major Customers

Our top 5 customers accounted for approximately 70% and 68% of net sales for the quarter ended September 30, 2007 and nine months ended September 30, 2007 compared to 88%, and 89% for the same periods in 2006 respectively.  In addition, the top 3 customer concentration was reduced to 53% for the quarter ended September 30, 2007 compared to 77% the same period in 2006.  We believe that to have a healthy company, we must diversify our customer base even further.  We believe that our ability to grow our core business depends on increasing sales to existing customers and on successfully attracting new customers. Customer contracts can be canceled and volume levels can be changed or delayed based on our customer’s performance and the end users’ markets which we have no control over. Although, we try to replace delayed, reduced or cancelled business as soon as possible, the timely replacement of delayed, canceled or reduced orders with new business cannot be ensured. In addition, we cannot assume that any of our current customers will continue to utilize our services. Consequently, our results of operations may be materially adversely affected.


Gross Profit 

For the quarter ended September 30, 2007 our gross profit was 26% compared to 24% and 21% in the same period in 2006 and 2005 respectively.   The improvement from 2005 to 2007 is primarily due to new customer base and improved operational efficiencies. Although our revenues were lower in 2007 than 2006, we were able to maintain profitability by improving our operations. Our gross profits could vary from period to period and is affected by a number of factors, including product mix, production efficiencies, component availability and costs, pricing, competition, customer requirements and unanticipated restructuring or inventory charges.  


Selling, General and Administrative (SG&A) Expenses 

For the quarter ended September 30, 2007 our SG&A expenses was 21% compared to 20% and 33% in the same period in 2006 and 2005 respectively.   The 1% increase in SG&A from 2006 to 2007 was due to lower revenues in 2007.  The improvement in our SG&A expenses from 2005 to 2007 was primarily due to higher revenue levels and more suitable facilities and improved personnel utilization.  


Net Income/ (Loss) from operations

For the quarter ended September 30, 2007 our net income from operations was .2% compared to net income of 1.6% and losses of (14%) for the same period in 2006 and 2005 respectively.   Improvements in net profits in 2006 and 2007 compared to 2005 are primarily due to increased revenue in 2006 and continued operational efficiencies in 2007.  


Liquidity and Capital Resources: 


PROBE MANUFACTURING, INC.

Condensed Statements of Cash Flows

for the nine months ended September 30,

 

 

 

 

 

2007

2006

2005

Net Cash provided / (Used) In Operating Activities

$       525,670

$       365,112

$     (918,772)

Cash Flows Used In Investing Activities

           (125,392)

           (155,750)

             (22,611)

Cash Flows Provided / (used)  By Financing Activities

           (405,092)

           (182,689)

             901,460

Net (Decrease) Increase in Cash and Cash Equivalents

 $         (4,814)

 $         26,673 

 $       (39,923)


For the nine month ended September 30, 2007, we provided net cash from our operating activities of $525,670 compared to net cash provided of $365,112 and net cash used in operating activities of ($918,772) for the same period in 2006 and 2005 respectively.  

For the nine month ended September 30, 2007 we also accelerated to pay down debt by $405,092 compared to $182,689 and raising of $901,460 from financing activities in the same period in 2006 and 2005 respectively.  We invested $125,393 in Lead Free Wave Solder equipment and BGA (Ball Grid Array) rework stations to secure future business associated with Rohs European Directive.  





 10

______________________________________________________________________________________________


            


Table of Contents


The following is a summary of certain obligations and commitments as of September 30, 2007 for continuing operations:


Capital Requirements for long-term Obligations

2007

2008

2009

2010

Notes Payable

 $164,643

 $ 872,359

                  -   

                  -   

Other Long term debt

16,500

45,425

24,612

            -   

Capital Lease Settlement  Obligations

                22,500

                90,000

                90,000

                90,000

Total

$379,300

$903,569

$113,822

$90,000



We reduced our interest rate from 20% to 12% in August 2006 by refinancing our lines of credit into term notes.


On July 9, 1997 and December 21, 1997, the Company entered into two lease agreements, with Crocker capital, which subsequently assigned the leases to The CIT Group.  In September 2004 the Company had outstanding balances of $457,604 and $556,293 on the two leases and was unable to make the monthly lease payments. As a result, the Company entered into a forbearance agreement with The CIT Group, with monthly payments of $7,500 and an early payment schedule as follows:


The CIT Group would release the Company and its guarantors if one of the following payments were made, less the total of all monthly payments made to that date:


$375,000 if paid by October 25 , 2004

$425,000 if paid by December 25, 2004

$500,000 if paid by June 25, 2005

$550,000 if paid by December 25, 2005

$600,000 if paid by June 25, 2006

$650,000 if paid by December 25, 2006

$700,000 if paid by June 25, 2007


On June 1, 2007 an amended forbearance agreement was entered into:


7)

In consideration of CIT entering into this Addendum, Probe will pay CIT the sum of $7,500 on or before June 25, 2007, which was paid.

8)

Recital B is amended to state that as of June 25, 2007 Probe’s payment obligation to CIT totals $457,500.

9)

Section 2.3 of the Forbearance Agreement is amended to state that probe will pay CIT the amount of $457,500 in sixty-one (61) monthly installments of $7,500 each, commencing on July 25, 2007 and ending on July 25, 2012. If at any time Probe elects to pay in full the remaining balance, upon 30 day written notice, CIT will provide a payoff figure for the remaining balance using a present value rate of 7.0%.

10)

The Company imputed interest at 7% over the term of the payments, which resulted in a present value of $384,025 at June 30, 2007.

11)

This resulted in a gain of $324,330.


We have a balloon payment of $707,716 in notes payables due on April 15 2008.  We are currently exploring venues to convert to equity; or extend the notes payable term by 18 to 36 month.



Off-balance Sheet Arrangement

We currently have no off-balance sheet arrangements.





 11

______________________________________________________________________________________________


            


Table of Contents


Item 3.     Controls and procedures


As of, the end of the period covered by this Quarterly Report on Form 10-QSB, an evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14 of the Securities Exchange Act of 1934).  Based  on  that  evaluation,  our  Chief Executive Officer and Chief Financial  Officer  concluded  that  our  disclosure controls and procedures are effective to ensure that information we are required to disclose in reports that we  file  or  submit  under the Securities Exchange Act of 1934 (i) is recorded, processed,  summarized  and  reported  within  the  time  periods  specified  in Securities  and Exchange Commission rules and forms, and (ii) is accumulated and communicated  to our management, including our Chief Executive Officer and Chief Financial  Officer, as appropriate, to allow timely decisions regarding required disclosure.  Our disclosure controls and procedures are designed to provide reasonable assurance that such information is accumulated and communicated to our management. Our disclosure controls and procedures include components of our internal control over financial reporting.  Management's  assessment  of the effectiveness  of our internal control over financial reporting is expressed at the  level  of  reasonable assurance that the control system, no matter how well designed  and operated, can provide only reasonable, but not absolute, assurance that  the  control  system's  objectives  will  be  met.


Changes in internal controls

There  was  no  change  in  our  internal  control over financial reporting that occurred  during  the  third  quarter  covered  by  this quarterly  report on Form 10-QSB  that  materially  affected,  or  is  reasonably  likely  to  materially affect,  our  internal  control  over  financial  reporting.



PART II - OTHER INFORMATION


Item 1.     Legal proceedings


We believe that there are no other claims or litigation pending, the outcome of which could have a material adverse effect on our financial condition or operating results.  However, if litigation should arise and the Company was to receive an unfavorable ruling, there is a possibility that it would have a material adverse impact on our financial condition, results of operations, or liquidity of the period in which the ruling occurs, or future periods.



Item 2.  Unregistered sales of equity securities and use of proceeds.


None.


Item 3.  Defaults upon senior securities.


Not Applicable.


Item 4.  Submission of matters to a vote of security holders.


None.


Item 5.  Other information.

None.





 12

______________________________________________________________________________________________


            


Table of Contents



Item  6.  Exhibits


Exhibit

No.

Exhibit Description

3.1

Articles of Incorporation (included as exhibit 3.1 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

3.2

Bylaws (included as exhibit 3.2 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

4.1

Certificate of Designation for Series A Convertible Preferred Stock, dated May 20, 2004 (included as exhibit 4.1 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

4.2

Certificate of Designation for Series B Convertible Preferred Stock dated December 31, 2004 (included as exhibit 4.2 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

4.3

Sample Series A Warrant Purchase Agreement (included as exhibit 4.3 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

4.4

Sample Series B Warrant Purchase Agreement (included as exhibit 4.4 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

4.5

Sample Amended Series A Warrant Purchase Agreement (included as exhibit 4.5 to the Form SB-2/A filed on November 25, 2005 and incorporated herein by reference

4.6

Sample Amended Series B Warrant Purchase Agreement (included as exhibit 4.6 to the Form SB-2/A filed on November 25, 2005 and incorporated herein by reference).

4.6

Certificate of Designation for Series C Convertible Preferred Stock dated May 25, 2006 (included as exhibit 4.1 to Form 8-K filed on June 14, 2006 and incorporated herein by reference).

4.7

Amended Certificate of Designation for Series C Convertible Preferred Stock dated August 7, 2006 (included as exhibit 4.1 to Form 8-K filed on August 14, 2006 and incorporated herein by reference).

4.8

Amended Certificate of Designation of Series C Convertible Preferred Stock dated May 25, 2006 (included as exhibit 4.1 to the Form 8-K filed on August 14, 2006 and incorporated herein by reference).

4.9

Sample Amended Series A Warrant Purchase Agreement (included as exhibit 10.1 to the Form 8-k filed on November 15, 2006 and incorporated herein by reference).

4.10

Sample Amended Series B Warrant Purchase Agreement (included as exhibit 10.2 to the Form 8-k filed on November 15, 2006 and incorporated herein by reference).

10.1

Lease agreement between Probe Manufacturing, Inc. (F.K.A. Probe Manufacturing Industries, Inc. and Reza Zarif and Kambiz Mahdi, dated May 2, 1997 (included as exhibit 10.1 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).  

10.2

Consulting  agreement  between  Probe Manufacturing Industries and Anthony Reed dated December 31, 2004 (included as exhibit 10.2 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.3

Legal retainer agreement between Probe Manufacturing, Inc. and Jeffrey Conrad dated (included as exhibit 10.3 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.4

Line of Credit agreement between Probe Manufacturing, Inc. and eFund Capital Partners, LLC dated January 1, 2005 (included as exhibit 10.4 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.5

Line of Credit agreement between Probe Manufacturing, Inc. and Ashford Capital, LLC dated January 1, 2005 (included as exhibit 10.5 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.6

Line of Credit agreement between Probe Manufacturing, Inc. and Benner Exemption Trust dated March 8, 2005 (included as exhibit 10.6 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.7

Line of Credit agreement between Probe Manufacturing, Inc. and Edward Lassiter dated March 22, 2005 (included as exhibit 10.7 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.8

Line of Credit agreement between Probe Manufacturing, Inc. and Rufina V. Paniego dated January 1, 2004  (included as exhibit 10.8 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.9

Promissory Note between Probe Manufacturing, Inc and Ashford Transitional Fund, L.P. dated September 20, 2004 (included as exhibit 10.9 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).





 13

______________________________________________________________________________________________


            


Table of Contents



10.10

Engagement Letter between Probe Manufacturing, Inc. and eFund Capital Partners, LLC dated May 20, 2004 (included as exhibit 10.10 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.11

Series A Convertible Preferred Stock Purchase Agreement with eFund Capital Partners, LLC dated May 20, 2004 (included as exhibit 10.11 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.12

Series A Convertible Preferred Stock Purchase Agreement with Reza Zarif dated May 20, 2004 (included as exhibit 10.12 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.13

Series A Convertible Preferred Stock Purchase Agreement with Kambiz Mahdi dated May 20, 2004. (included as exhibit 10.13 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.14

Series B Convertible Preferred Stock Purchase Agreement with eFund Capital Partners, LLC dated December 31, 2004 (included as exhibit 10.14 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10. 15

Series B Convertible Preferred Stock Purchase Agreement with Reza Zarif dated December 31, 2004 (included as exhibit 10.15 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.16

Series B Convertible Preferred Stock Purchase Agreement with Kambiz Mahdi dated December 31, 2004 (included as exhibit 10.16 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.17

Agreement to Cancel and Return shares of common stock between Probe and eFund Capital Partners, LLC, Ashford Capital, LLC, Reza Zarif, Kambiz Mahdi, dated December 31, 2004 (included as exhibit 10.17 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.18

Promissory note with eFund Capital Partners, LLC dated October 12, 2004 (included as exhibit 10.18 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.19

Promissory note with Rufina V. Paniego dated July 1, 2004 (included as exhibit 10.19 to the Form SB-2/A filed on June 10, 2005 and incorporated herein by reference).

10.20

Sample purchase order agreement with Celerity, Inc (included as exhibit 10.20 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

10.21

Sample purchase order agreement with Newport Corporation (included as exhibit 10.21 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

10.22

Sample purchase order agreement with Asymtek Corporation (included as exhibit 10.22 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

10.23

Sample purchase order agreement with Jetline Engineering Corporation (included as exhibit 10.23 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

10.24

Sample purchase order agreement with our supplier Future Active, Inc (included as exhibit 10.24 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

10.25

Sample purchase order agreement with our supplier Arrow Electronics, Inc. (included as exhibit 10.25 to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

10.26

Lease Agreement between Probe Manufacturing, Inc. and Mitchell Fitch, LLC, dated November 15, 2005  (included as Exhibit 10.26 to the Form 10-KSB filed on April 14, 2006 and incorporated herein by reference).

10.27

Employment Agreement with Reza Zarif, Chief Executive Officer of Probe Manufacturing, Inc. (included as exhibit 10.1 to Form 8-K filed on June 14, 2006 and incorporated herein by reference).

10.27

Series C Convertible Preferred Exchange Agreement with eFund Capital Partners, LLC (included as exhibit 10.2 to Form 8-K filed on June 14, 2006 and incorporated herein by reference).

10.28

Series C Convertible Preferred Exchange Agreement with Reza Zarif (included as exhibit 10.3 to Form 8-K filed on June 14, 2006 and incorporated herein by reference).

10.29

Series C Convertible Preferred Exchange Agreement with Kambiz Mahdi (included as exhibit 10.4 to Form 8-K filed on June 14, 2006 and incorporated herein by reference).

10.30

Amended Series C Convertible Preferred Exchange Agreement with eFund Capital Partners, LLC (included as exhibit 10.1 to Form 8-K filed on August 14, 2006 and incorporated herein by reference).

10.31

Amended Series C Convertible Preferred Exchange Agreement with Reza Zarif (included as exhibit 10.2 to Form 8-K filed on August 14, 2006 and incorporated herein by reference).





 14

______________________________________________________________________________________________


            


Table of Contents



10.32

Amended Series C Convertible Preferred Exchange Agreement with Kambiz Mahdi (included as exhibit 10.3 to Form 8-K filed on August 14, 2006 and incorporated herein by reference).

10.33

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Kambiz Mahdi dated August 10, 2006 (included as exhibit 10.1 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.34

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Reza Zarif dated August 10, 2006 (included as exhibit 10.2 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.35

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Frank Kavanaugh dated August 10, 2006 (included as exhibit 10.3 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.36

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Kambiz Mahdi dated August 10, 2006 (included as exhibit 10.4 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.37

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Reza Zarif dated August 10, 2006 (included as exhibit 10.5 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.38

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Rufina Paniego dated August 10, 2006 (included as exhibit 10.6 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.39

Amended Line of Credit agreement between Probe Manufacturing, Inc. and eFund Capital Partners, LLC dated August 10, 2006 (included as exhibit 10.7 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.40

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Benner Exemption Trust dated August 10, 2006 (included as exhibit 10.8 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.41

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Ed Lassiter dated August 10, 2006 (included as exhibit 10.9 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.42

Amended Line of Credit agreement between Probe Manufacturing, Inc. and William Duncan dated August 10, 2006 (included as exhibit 10.10 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.43

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Hoa Mai dated August 10, 2006 (included as exhibit 10.11 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.44

Amended Line of Credit agreement between Probe Manufacturing, Inc. and Ashford Transition Fund dated August 10, 2006 (included as exhibit 10.12 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.45

Employee Profit Sharing Plan (included as exhibit 10.13 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

10.46

Probe Manufacturing 2006 Employee Incentive Stock Option Plan (included as exhibit 10.14 to the Form 8-K filed on August 23, 2006 and incorporated herein by reference).

16.1

Letter from Michael Johnson & Company, LLC dated January 04, 2006 (included as exhibit 10.20to the Form SB-2/A filed on September 26, 2005 and incorporated herein by reference).

14.1

Code of Ethics filed (included as Exhibit 14.1 to the Form 10-KSB filed on April 14, 2006 and incorporated herein by reference).

21.1  

List  of  Subsidiaries (included as Exhibit 21.1 to the Form 10-KSB filed on April 14, 2006 and incorporated herein by reference).

23.1  

Consent of Jaspers + Hall, PC - Independent Auditors to the Form 10-K filed

March 21, 2006, (included as Exhibit 23.1 to the Form 10-KSB filed on April 14, 2006 and incorporated herein by reference).

31.1

Certification of the Chief Executive Officer pursuant to Section 302 of the

Sarbanes-Oxley  Act  of  2002.

31.2

Certification of the Chief Financial Officer pursuant to Section 302 of the

Sarbanes-Oxley  Act  of  2002.

32.1  

Certification  of  Officers pursuant to 18 U.S.C. Section 1350, as adopted

pursuant  to  Section  906  of  the  Sarbanes-Oxley  Act  of  2002.






 15

______________________________________________________________________________________________


            


Table of Contents


Item  7.  Reports Filed on Form 8-K


None.


SIGNATURES


In accordance with the requirements of the Exchange Act, the Registrant has caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.



Date:  November 13, 2007

              Probe Manufacturing, Inc.


                                  

        

       /s/ Reza Zarif

                                                                                                           __________________

                                                                                                          Reza Zarif

                                                                                                          Chief Executive Officer



Dated:   November 13, 2007

                         

                                                                      /s/ John Bennett

      ___________________

                                                  John Bennett

                                                                                Chief Financial Officer







 16

______________________________________________________________________________________________